SignalChem Diagnostics

State-of-the-art IVD solutions

SignalChem Diagnostics was founded in 2018 as a subsidiary of SignalChem Lifesciences, a biotech company based in Richmond, British Columbia, Canada. The founding of SignalChem Diagnostics was driven by the increasing demand for accurate and reliable raw materials for diagnostic tools. SignalChem Lifesciences was already well-established in the biotech industry, having been founded in 2004.

SignalChem Diagnostics began its operations by building on the expertise of its parent company in the areas of protein expression, purification, and characterization. The company developed a range of diagnostic tools based on these technologies, including ELISA assays, lateral flow assays and CRISPR-based nucleic acid target detection. Since its founding, SignalChem Diagnostics has continued to expand its product portfolio, offering a range of products: from Covid-19 related products to CRISPR Cas Enzymes involved in novel CRISPR-based molecular diagnostic tests for human, animal and plant applications.

 

Product Range:

  • Molecular diagnostics-related products
  • Immunodiagnostics
  • CRISPR associated proteins
  • Clinical chemistry
  • COVID-19
  • General reagents

https://signalchemdx.com/

Show Product

Other Partners

Reliance Biosciences

Reliance Biosciences

LipoMin™ EV purification

Reed Biotech

Reed Biotech

Biological immune protein research

EnkiLife

EnkiLife

Cell biology

Sanyou Bio

Sanyou Bio

Innovative Biologics for Research and Development

Apop Biosciences

Apop Biosciences

Powering cell stress detection